This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linde, H.-J.
Right arrow Articles by Lehn, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linde, H.-J.
Right arrow Articles by Lehn, N.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2002, p. 2696-2697, Vol. 40, No. 7
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.7.2696-2697.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

CASE REPORT

Septicemia Due to Acinetobacter junii

Hans-Jörg Linde,1* Joachim Hahn,2 Ernst Holler,2 Udo Reischl,1 and Norbert Lehn1

Institute for Medical Microbiology and Hygiene, University of Regensburg,1 Department of Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany2

Received 19 February 2002/ Returned for modification 8 April 2002/ Accepted 29 April 2002

ABSTRACT

Acinetobacter spp. are considered to be emerging nosocomial pathogens. Acinetobacter junii is a rare cause of disease in humans and was associated mainly with bacteremia in preterm infants and pediatric oncologic patients. In this report we describe a case of catheter-related infection by A. junii in an adult oncologic patient. Application of molecular methods for precise species identification of Acinetobacter spp. will help to further clarify their role as human pathogens.

CASE REPORT

A 39-year-old female was admitted to the hospital for implantation of a tunneled Hickman-catheter. The patient suffered from long-standing polycythemia vera and subsequent osteomyelofibrosis, and the catheter was placed in preparation of an allogeneic stem cell transplantation. Placement of the catheter was uneventful, and 2 days later the patient was dismissed temporarily from the hospital to allow for a weekend of recreation. Management of the freshly implanted catheter was left to the care of the patient, who was an experienced anesthesiologist (working in an outpatient children's clinic). Eight days after the placement of the catheter and 4 days after the beginning of conditioning treatment with total body irradiation and fludarabine, she developed temperatures up to 39°C. Four sets of blood cultures were drawn in parallel from the different catheter lumens and peripheral veins on two consecutive days. Empirical treatment with ceftazidime was started at day 1 of the fever after the first set of cultures. All four blood cultures from day 1 and the two cultures from the catheter of day 2 grew Acinetobacter junii from the aerobic blood culture bottle. In the cases of positive paired central and peripheral cultures, the times to detection were 13 versus 16.2 h and 17.8 versus 17.2 h, respectively (BacT/ALERT FA; Organon Teknika, Durham, N.C.), further suggesting catheter-related infection by the first pair of bottles (3). When these results became available, the catheter was removed. There was complete resolution of signs and symptoms, and clearance of bacteremia was documented by repeated blood cultures. No further complications due to A. junii were noted in the course of the treatment. Interestingly, from the day the catheter was placed until the time the catheter-related infection was diagnosed, the patient had received treatment for selective decontamination of the gut with oral trimethoprim-sulfamethoxazole (SXT) for 2 days, followed by ciprofloxacin for 6 days because of intolerance of the patient to SXT.

Acinetobacter junii is classified according to DNA-DNA hybridization studies as genomospecies 5 of the genus Acinetobacter (4), members of which have recently received considerable attention as a cause of nosocomial infections (1, 7, 9, 16). A. junii is a rare cause of disease, with documented cases of septicemia in neonates (2, 15) and pediatric oncology patients (10) and a case of corneal perforation (13). The true incidence of infections by A. junii might be underestimated, since phenotypical identification is difficult (1) and may require analysis of 16S rDNA (8) or DNA-DNA-hybridization studies (7). We have reported a case of catheter-related septicemia due to A. junii in an adult oncologic patient.

Microbiology. Blood culture isolates appeared as coccobacillary catalase-positive and oxidase-negative gram-negative rods. After 24 h, colonies on sheep blood agar and MacConkey agar were about 1.5 mm in diameter, smooth, and colorless. They were identified as Acinetobacter lwoffii and A. junii by the VITEK I system (biocode 40000000000, 98% presumptive identification, VITEK software version VTK-R07.01; bioMérieux Vitek, Inc., Hazelwood, Mo.). PCR amplification of the complete 16S rRNA gene was performed with genomic DNA according to a previously published protocol (12). Amplification products were subjected to direct sequencing, and a 100% match to GenBank sequence Z93438 of A. junii (8) was noted. Antibiotic susceptibility was determined according to NCCLS guidelines for disk diffusion (11), and isolates of all six positive blood cultures were susceptible to piperacillin, piperacillin-sulbactam, carbapenems, expanded- and broad-spectrum cephalosporins, aztreonam, fluoroquinolones, SXT, tetracycline, and aminoglycosides but resistant to ampicillin, mezlocillin, cefazolin, and fosfomycin. The culture of the removed catheter tip remained sterile, most probably due to the empirical treatment with ceftazidime. Also, A. junii was not isolated from any subsequent specimen from the patient.

Discussion. No attempts to identify the source of the infection by A. junii were made in the present case. Placement of the catheter was performed under maximum sterile precautions in an operating theatre. However, vascular devices as a portal of entry for Acinetobacter sp. have been noted before (6). Improper handling of the catheter by the patient at home also cannot be ruled out. In the study of Kappstein (10), aerators of water faucets were found to be contaminated with the outbreak strain of A. junii. In the case of corneal perforation, a thorn had traumatized the cornea, with subsequent instillation of plant juice for treatment (13). Acinetobacter spp. are found in nature ubiquitously (1), and therefore no common source of infection might be delineated.

Members of the genus Acinetobacter have been classified according to DNA-DNA hybridization (14), and at present no simple phenotypic scheme for the precise identification of Acinetobacter sp. exists (1, 5). A. junii (genomospecies 5), which is asaccharolytic, can be differentiated from A. lwoffii by its ability to grow at 41°C and positive reactions for citrate and Mollers arginine. Sequence analysis of the 16S rDNA or the gyrB gene is rapid and offers an alternative for the differentiation of the DNA groups of this genus (8, 17, 18).

The present case represents the first documented catheter-related infection by A. junii in an adult oncologic patient. It adds to the growing list of infections associated with this organism, and the application of molecular methods for precise species identification of Acinetobacter spp. will help to further clarify their roles as human pathogens.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Franz-Josef-Strauß-Allee 11, D-93042 Regensburg, Germany. Phone: 49-941-944-6461. Fax: 49-941-944-6439. E-mail: Hans-Joerg.Linde{at}klinik.uni-regensburg.de. Back

REFERENCES

    1
  1. Bergogne-Berezin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.[Medline]
    2. 2
  2. Bernards, A. T., A. J. de Beaufort, L. Dijkshoorn, and C. P. van Boven. 1997. Outbreak of septicaemia in neonates caused by Acinetobacter junii investigated by amplified ribosomal DNA restriction analysis (ARDRA) and four typing methods. J. Hosp. Infect. 35:129-140.[CrossRef][Medline]
    3. 3
  3. Blot, F., G. Nitenberg, E. Chachaty, B. Raynard, N. Germann, S. Antoun, A. Laplanche, C. Brun-Buisson, and C. Tancrede. 1999. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 354:1071-1077.[CrossRef][Medline]
    4. 4
  4. Bouvet, P. J., and P. A. Grimont. 1986. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int. J. Syst. Bacteriol. 36:228-240.[Abstract/Free Full Text]
    5. 5
  5. Bouvet, P. J., and P. A. Grimont. 1987. Identification and biotyping of clinical isolates of Acinetobacter. Ann. Inst. Pasteur Microbiol. 138:569-578.[CrossRef][Medline]
    6. 6
  6. Forster, D. H., and F. D. Daschner. 1998. Acinetobacter species as nosocomial pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 17:73-77.[Medline]
    7. 7
  7. Horrevorts, A., K. Bergman, L. Kollee, I. Breuker, I. Tjernberg, and L. Dijkshoorn. 1995. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J. Clin. Microbiol. 33:1567-1572.[Abstract]
    8. 8
  8. Ibrahim, A., P. Gerner-Smidt, and W. Liesack. 1997. Phylogenetic relationship of the twenty-one DNA groups of the genus Acinetobacter as revealed by 16S ribosomal DNA sequence analysis. Int. J. Syst. Bacteriol. 47:837-841.[Abstract/Free Full Text]
    9. 9
  9. Jellison, T. K., P. S. Mckinnon, and M. J. Rybak. 2001. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam. Pharmacotherapy 21:142-148.[CrossRef][Medline]
    10. 10
  10. Kappstein, I., H. Grundmann, T. Hauer, and C. Niemeyer. 2000. Aerators as a reservoir of Acinetobacter junii: an outbreak of bacteraemia in paediatric oncology patients. J. Hosp. Infect. 44:27-30.[CrossRef][Medline]
    11. 11
  11. National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial disk susceptibility tests; approved standard, 7th ed. NCCLS document M2-A7. National Committee for Clinical Laboratory Standards, Wayne, Pa.
    12. 12
  12. Neubauer, H., U. Reischl, J. Köstler, S. Aleksic, E. J. Finke, and H. Meyer. 1999. Variations in the 16S rRNA gene sequence of Yersinia enterocolitica influence the specificity of molecular identification systems. Zentbl. Bakteriol. 289:329-337.
    13. 13
  13. Prashanth, K., M. P. Ranga, V. A. Rao, and R. Kanungo. 2000. Corneal perforation due to Acinetobacter junii: a case report. Diagn. Microbiol. Infect. Dis. 37:215-217.[CrossRef][Medline]
    14. 14
  14. Tjernberg, I., and J. Ursing. 1989. Clinical strains of Acinetobacter classified by DNA-DNA hybridization. APMIS 97:595-605.[Medline]
    15. 15
  15. Vaneechoutte, M., A. Elaichouni, K. Maquelin, G. Claeys, A. Van Liedekerke, H. Louagie, G. Verschraegen, and L. Dijkshoorn. 1995. Comparison of arbitrarily primed polymerase chain reaction and cell envelope protein electrophoresis for analysis of Acinetobacter baumannii and A. junii outbreaks. Res. Microbiol. 146:457-465.[Medline]
    16. 16
  16. Villers, D., E. Espaze, M. Coste-Burel, F. Giauffret, E. Ninin, F. Nicolas, and H. Richet. 1998. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann. Intern. Med. 129:182-189.[Abstract/Free Full Text]
    17. 17
  17. Yamamoto, S., P. J. Bouvet, and S. Harayama. 1999. Phylogenetic structures of the genus Acinetobacter based on gyrB sequences: comparison with the grouping by DNA-DNA hybridization. Int. J. Syst. Bacteriol. 49:87-95.[Abstract/Free Full Text]
    18. 18
  18. Yamamoto, S., and S. Harayama. 1996. Phylogenetic analysis of Acinetobacter strains based on the nucleotide sequences of gyrB genes and on the amino acid sequences of their products. Int. J. Syst. Bacteriol. 46:506-511.[Abstract/Free Full Text]

Journal of Clinical Microbiology, July 2002, p. 2696-2697, Vol. 40, No. 7
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.7.2696-2697.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Dortet, L., Legrand, P., Soussy, C.-J., Cattoir, V. (2006). Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens. J. Clin. Microbiol. 44: 4471-4478 [Abstract] [Full Text]  
  • Ecker, J. A., Massire, C., Hall, T. A., Ranken, R., Pennella, T.-T. D., Agasino Ivy, C., Blyn, L. B., Hofstadler, S. A., Endy, T. P., Scott, P. T., Lindler, L., Hamilton, T., Gaddy, C., Snow, K., Pe, M., Fishbain, J., Craft, D., Deye, G., Riddell, S., Milstrey, E., Petruccelli, B., Brisse, S., Harpin, V., Schink, A., Ecker, D. J., Sampath, R., Eshoo, M. W. (2006). Identification of Acinetobacter Species and Genotyping of Acinetobacter baumannii by Multilocus PCR and Mass Spectrometry.. J. Clin. Microbiol. 44: 2921-2932 [Abstract] [Full Text]  
  • Rodriguez-Bano, J., Marti, S., Ribera, A., Fernandez-Cuenca, F., Dijkshoorn, L., Nemec, A., Pujol, M., Vila, J. (2006). Nosocomial Bacteremia Due to an As Yet Unclassified Acinetobacter Genomic Species 17-Like Strain. J. Clin. Microbiol. 44: 1587-1589 [Abstract] [Full Text]  
  • Fenollar, F., Roux, V., Stein, A., Drancourt, M., Raoult, D. (2006). Analysis of 525 Samples To Determine the Usefulness of PCR Amplification and Sequencing of the 16S rRNA Gene for Diagnosis of Bone and Joint Infections.. J. Clin. Microbiol. 44: 1018-1028 [Abstract] [Full Text]  
  • Peleg, A. Y., Franklin, C., Walters, L. J., Bell, J. M., Spelman, D. W. (2006). OXA-58 and IMP-4 Carbapenem-Hydrolyzing {beta}-Lactamases in an Acinetobacter junii Blood Culture Isolate from Australia. Antimicrob. Agents Chemother. 50: 399-400 [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linde, H.-J.
Right arrow Articles by Lehn, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linde, H.-J.
Right arrow Articles by Lehn, N.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»